Literature DB >> 17177025

Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.

Robert Schuon1, Jürgen Brieger, Ulf R Heinrich, Yeduha Roth, Witold Szyfter, Wolf J Mann.   

Abstract

Angiogenic factors are discussed to participate in growth and promotion of juvenile nasopharyngeal angiofibroma (JNA). However, only few data are available and mechanisms remain unclear. In the presented study we analysed the expression and subcellular distribution of several angiogenic growth factors and receptors potentially involved in JNA-growth and -vascularisation. In a retrospective, descriptive, multicenter-study, we analysed 13 formalin-fixed, paraffin-embedded or cryopreserved JNA-tumors (eleven primary tumors and two recurrent ones) after immunohistochemical staining. We used monoclonal antibodies specific for transforming growth factor beta 1 (TGF-beta(1)), basic fibroblast growth factor (bFGF), the VEGF-receptors 1 and -2 (FLT-1 and FLK-1), and the hypoxia inducible factor (Hif-1alpha). Data were compared to the vessel density. Quantitative analysis of staining intensities was performed by a computer assisted quantification technique. Endothelial and stromal compartments of the samples were analysed separately. Data were compared to vessel densities and patients data. The VEGF-Receptor-2 (FLK) was frequently unregulated in the stroma and endothelium of those samples with high vessel densities. Similarly, we observed high bFGF- and TGF-beta(1) levels in the stroma of strong vascularised samples. No correlations of expression levels to patients' data were found. The reported data support the concept of JNA-growth and -vascularisation driven by factors released from stromal fibroblasts. Therefore, inhibition of these factors might be beneficial for the therapy of inoperable JNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177025     DOI: 10.1007/s00405-006-0202-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

1.  COX-2 expression in the guinea pig cochlea is partly altered by moderate sound exposure.

Authors:  Ulf-Rüdiger Heinrich; Jürgen Brieger; Oxana Selivanova; Ralph Feltens; Antje Eimermacher; Dirk Schäfer; Wolf J Mann
Journal:  Neurosci Lett       Date:  2005-11-10       Impact factor: 3.046

2.  Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts.

Authors:  H Pilch; K Schlenger; E Steiner; P Brockerhoff; P Knapstein; P Vaupel
Journal:  Int J Gynecol Cancer       Date:  2001 Mar-Apr       Impact factor: 3.437

3.  Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis.

Authors:  H A Lehr; C M van der Loos; P Teeling; A M Gown
Journal:  J Histochem Cytochem       Date:  1999-01       Impact factor: 2.479

4.  Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.

Authors:  Güleser Saylam; O Taşhin Yücel; Arzu Sungur; Metin Onerci
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-07-14       Impact factor: 1.675

5.  Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases.

Authors:  Alberto Labra; Rogelio Chavolla-Magaña; Adriana Lopez-Ugalde; Jorge Alanis-Calderon; Angel Huerta-Delgado
Journal:  Otolaryngol Head Neck Surg       Date:  2004-04       Impact factor: 3.497

6.  The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.

Authors:  David M Roberts; Joseph B Kearney; Jennifer H Johnson; Michael P Rosenberg; Rakesh Kumar; Victoria L Bautch
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases.

Authors:  H C Hwang; S E Mills; K Patterson; A M Gown
Journal:  Mod Pathol       Date:  1998-11       Impact factor: 7.842

8.  Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas.

Authors:  Z Gatalica
Journal:  Cancer Lett       Date:  1998-05-15       Impact factor: 8.679

9.  Juvenile nasopharyngeal fibroma: androgen receptors and their significance for tumor growth.

Authors:  R Hagen; G Romalo; B Schwab; F Hoppe; H U Schweikert
Journal:  Laryngoscope       Date:  1994-09       Impact factor: 3.325

10.  Tumor induction of VEGF promoter activity in stromal cells.

Authors:  D Fukumura; R Xavier; T Sugiura; Y Chen; E C Park; N Lu; M Selig; G Nielsen; T Taksir; R K Jain; B Seed
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

View more
  8 in total

1.  Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.

Authors:  Suely Nonogaki; Heloisa G A Campos; Ossamu Butugan; Fernando A Soares; Flávia Regina Rotea Mangone; Humberto Torloni; M Mitzi Brentani
Journal:  Exp Ther Med       Date:  2010-08-26       Impact factor: 2.447

2.  Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?

Authors:  Suvi Renkonen; Valtteri Häyry; Päivi Heikkilä; Ilmo Leivo; Caj Haglund; Antti A Mäkitie; Jaana Hagström
Journal:  Virchows Arch       Date:  2010-11-27       Impact factor: 4.064

3.  Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.

Authors:  Anupam Mishra; Subhash Chandra Mishra; Ashoak Mani Tripathi; Amita Pandey
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-31       Impact factor: 2.503

4.  The changing surgical management of juvenile nasopharyngeal angiofibroma.

Authors:  Suvi Renkonen; Jaana Hagström; Jyrki Vuola; Mika Niemelä; Matti Porras; Sanna-Maria Kivivuori; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-17       Impact factor: 2.503

5.  Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing.

Authors:  Joel W Jones; Shireen Usman; Jacob New; Andrew Holcomb; Sumedha Gunewardena; Ossama Tawfik; Larry Hoover; Daniel Bruegger; Sufi Mary Thomas
Journal:  Otolaryngol Head Neck Surg       Date:  2018-04-10       Impact factor: 3.497

6.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

7.  Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis.

Authors:  Konstantinos Papaspyrou; Christoph Brochhausen; Irene Schmidtmann; Kai Fruth; Haralampos Gouveris; James Kirckpatrick; Wolf Mann; Juergen Brieger
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

8.  A seven-year experience with patients with juvenile nasopharyngeal angiofibroma.

Authors:  Alfredo Lara Gaillard; Vanessa Menegatti Anastácio; Vânia Belintani Piatto; José Victor Maniglia; Fernando Drimel Molina
Journal:  Braz J Otorhinolaryngol       Date:  2010 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.